The Effect of Nano Chitosan Surface Coating on White Spot Lesions Development in Clear Aligner Therapy Patients
The Effect of Nano Chitosan Carboxymethyle Methyle Cellulose Surface Coating on White Spot Lesions Development in Patients With Clear Aligner Therapy: Prospective Randomized Controlled Clinical Trial
1 other identifier
interventional
53
1 country
1
Brief Summary
In this study, it was intended to investigate the effect of nano Chitosan (antimicrobial agent) coating on clear aligner orthodontic appliance if it reduces the incidence of white spot lesions (demineralization) of enamel surfaces.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
CompletedFirst Submitted
Initial submission to the registry
July 7, 2026
CompletedFirst Posted
Study publicly available on registry
July 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2026
ExpectedJuly 20, 2026
July 1, 2026
9 months
July 7, 2026
July 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
White spot lesion area
It measures the area of enamel demineralization in pixels (Using the QLF system)
3 months
Mean of fluorescence loss (Delta F) in percent
It measures the percentage of fluorescence loss in the white spot lesion compared to that of sound enamel reflecting the amount of mineral loss using the QLF system
3 months
Study Arms (2)
Intervention
EXPERIMENTALChitosan nanoparticle coating of the clear orthodontic aligners that will be used by the participants
Control
PLACEBO COMPARATORThe clear orthodontic aligners that will be used by the participants are not coated with anything.
Interventions
Clear orthodontic aligners will be coated with nanoparticle sized Chitosan to investigate its anti-microbial effect on development of white spot lesions underneath the aligners
Eligibility Criteria
You may qualify if:
- Patients presenting with mild to moderate malocclusion (sagittal, vertical, transverse discrepancies, or crowding) that could be treated using clear aligners within a maximum treatment period of one year and without the need for extraction therapy.
- Medically healthy patients with no systemic diseases or medical conditions that could affect enamel integrity, salivary flow, oral hygiene status, or periodontal health.
- Patients with no history of previous orthodontic treatment, dental trauma, or parafunctional habits such as bruxism.
- Patients with good oral hygiene and absence of active periodontal disease, including gingivitis or periodontitis.
- Patients willing to comply with the prescribed clear aligner wear protocol for a minimum of 22 hours per day.
- Patients who agreed to participate in the study and signed the informed consent form.
You may not qualify if:
- Previous orthodontic treatment that could influence baseline enamel condition or white spot lesion assessment.
- Presence of active carious lesions, cavitated lesions, severe enamel hypoplasia, or developmental enamel defects.
- Extensive restorations on anterior teeth that could interfere with Quantitative Light-Induced Fluorescence (QLF) imaging and analysis.
- Systemic diseases or medical conditions affecting salivary flow, enamel integrity, oral hygiene, or periodontal health.
- Use of medications known to affect salivary secretion, enamel mineralization, or oral microbial balance.
- Poor oral hygiene or presence of active periodontal disease, including gingivitis or periodontitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Postgraduate Orthodontic Clinics
Irbid, 22110, Jordan
Study Officials
- STUDY DIRECTOR
Susan Al-Khateeb
Jordan University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2026
First Posted
July 20, 2026
Study Start
October 12, 2025
Primary Completion
June 30, 2026
Study Completion (Estimated)
October 29, 2026
Last Updated
July 20, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
The data will be provided at reasonable request